Fondazione I.R.C.C.S. Ca' Granda Ospedale Maggiore Policlinico, Neonatal Intensive Care Unit, Department of Clinical Science and Community Health, University of Milan, Milan, Italy.
Humanitas University, Pieve Emanuele, Milan, Italy.
Adv Exp Med Biol. 2019;1125:37-45. doi: 10.1007/5584_2018_314.
Increasing evidence indicates that many of the health beneficial effects associated with the establishment of a symbiotic gut microbiota are driven by bacterial metabolic by-products.The term "postbiotics" indicates any soluble factor resulting from the metabolic activity of a live bacteria or any released molecule capable of providing health benefits through a direct or indirect mechanism.Alterations in preterm gut colonization associated with the intestinal barrier immaturity and the increased reactivity of the intestinal mucosa to colonizing bacteria have been implicated in the pathogenesis of necrotizing enterocolitis. Recent advances in the comprehension of the postbiotic biological effects and related mechanisms, some of them reviewed here, indicate that postbiotics may be a promising effective preventive strategy against necrotizing enterocolitis while avoiding the risk of administering live microorganisms to preterm infants that could translocate and cause infection. However, data from trials investigating the efficacy of postbiotics for the prevention of necrotizing enterocolitis in preterm infants are needed, and issues regarding their optimal regimen and start and duration of treatment need to be addressed.
越来越多的证据表明,许多与共生肠道微生物群建立相关的有益健康的影响是由细菌代谢副产物驱动的。“后生元”一词表示由活菌的代谢活动产生的任何可溶性因子,或任何通过直接或间接机制能够提供健康益处的释放分子。与肠道屏障不成熟和肠黏膜对定植细菌的反应性增加相关的早产儿肠道定植改变,与坏死性小肠结肠炎的发病机制有关。后生元的生物学效应和相关机制的理解的最新进展,其中一些在此综述,表明后生元可能是一种有前途的有效预防策略,以防止坏死性小肠结肠炎,同时避免给早产儿施用活体微生物的风险,这可能会移位并导致感染。然而,需要研究后生元预防早产儿坏死性小肠结肠炎的疗效的试验数据,并且需要解决关于其最佳方案以及治疗的开始和持续时间的问题。